Harmony Biosciences Holdings Inc (HRMY) reports robust financial performance and strategic progress, despite facing ...

According to recent market analysis, the global PARP inhibitor market, valued at USD 6,279.90 million in 2024, is set to witness exceptional growth, reaching USD 16,153.50 million by 2034. This ...

Polaryx Logo PARAMUS, NJ, UNITED STATES, February 26, 2025 /EINPresswire / -- Polaryx Therapeutics , a late-stage clinical biotech company dev ...